Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rheumatoid arthritis (RA) based on standard 2010 classification criteria
- People aged 18 to 84 years
- People whose RA is currently moderately or highly active, based on a standard disease activity score (called CDAI, scored above 10)
- People with no more than 2 joints that are visibly swollen (out of 44 joints checked)
- People who have been on a single stable RA medication (any standard type) for at least 3 months
- People who are either not taking steroid tablets, or who have been on a stable low dose (no more than 5 mg/day of prednisone or equivalent) for at least 4 weeks
- People who have not had a steroid injection into a joint within the past 4 weeks
- People who have been on a stable dose of anti-inflammatory pain medication (such as ibuprofen), or not taking any, for at least 1 week
- People who are willing and able to give written consent and follow the study requirements
Who may not be able to join:
- People who have a joint that the doctor judges to be completely destroyed, as seen on ultrasound
- People currently experiencing RA-related blood vessel inflammation or other serious disease activity outside the joints (other than rheumatoid nodules) that the doctor considers a significant health risk
- People whose arthritis first appeared before the age of 18
- People who have surgery planned during the study period on any joint being examined in the trial
- People currently experiencing a serious illness that requires a hospital stay
- People with an active infection, or who have been diagnosed with cancer within the past 5 years
- People for whom certain RA medications (biological or targeted synthetic DMARDs) are medically unsuitable, based on official prescribing guidelines
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390474581862
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Non-inferiority of ultrasound-based decision strategy compared to clinically-based strategy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.